When one unnecessary procedure leads to many…
What happens when one low-value test leads to a "cascade" of expensive and harmful procedures? More
What happens when one low-value test leads to a "cascade" of expensive and harmful procedures? More
We know that consolidation among hospitals and insurance companies leads to higher prices. But what about consolidation in other areas of health care? More
Why measuring the outcomes of deprescribing is key for culture change, from family physician Maisha Draves at Kaiser Permanente. More
Is the FDA's accelerated approval program resulting in better cancer drugs? Two new studies provide insight... More
The approval of a new gene therapy to treat spinal muscular atrophy has created a hot debate in the health policy world about whether or not the drug's $2.1 million price tag is too expensive or a fair price. More
While we rush to fix the opioid crisis, are we ignoring another widespread drug problem? More
A group of pharmacists from Lifespan/Rhode Island Hospital answer our questions about how pharmacists can promote deprescribing. More
Is our health care system prepared to treat more behavioral health problems in younger people? So far, the answer is no. More
Health care experts explain the potential downsides to the artificial intelligence "revolution." More
In Health Affairs Grantwatch blog, Shannon Brownlee and Terry Fulmer describe how the Lown Institute and John A. Hartford Foundation are working together to reduce medication overload. More
Popular health news often fails to reflect the incrementalism and nuance of medical discoveries, instead hyping unproven treatments. Can we save health journalism? More
Much of the political discourse around health focuses on expanding access to health insurance. But how much does health care really matter for health? More
When we think of initiatives to improve health care value, we generally think of policies to reduce volume or price. But what if there was another way to improve the bang for each health care buck? More
Physician practices are increasingly being bought up by private equity firms. What does this mean for quality of care and overuse? More
Why is palliative care still underutilized, despite the improvements in quality of life it offers patients with serious illness? More
Solutions for increasing racial and gender equity in health care, from the Atlantic Pulse conference. More
A new study in JAMA shows how often cardiovascular trials contain misleading information... More
Clinicians and public health experts are calling attention to the health risks and financial implications of widespread loneliness. More
At the Atlantic Pulse conference, health care experts proposed several "fixes" for the medical education system. More
Why is the culture the drives overprescribing so tough to change? Read the new op-ed from Theresa Brown, RN, to find out more! More